CN104758235A - Eye-pouch-removing and anti-inflammation eye essence liquid - Google Patents
Eye-pouch-removing and anti-inflammation eye essence liquid Download PDFInfo
- Publication number
- CN104758235A CN104758235A CN201510119659.3A CN201510119659A CN104758235A CN 104758235 A CN104758235 A CN 104758235A CN 201510119659 A CN201510119659 A CN 201510119659A CN 104758235 A CN104758235 A CN 104758235A
- Authority
- CN
- China
- Prior art keywords
- eye
- essence
- extract
- extracting solution
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 26
- 206010061218 Inflammation Diseases 0.000 title abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 40
- 239000000284 extract Substances 0.000 claims abstract description 21
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 14
- 240000003394 Malpighia glabra Species 0.000 claims abstract description 14
- 235000014837 Malpighia glabra Nutrition 0.000 claims abstract description 14
- 235000008990 Prunus myrtifolia Nutrition 0.000 claims abstract description 14
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 14
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 14
- 239000000243 solution Substances 0.000 claims description 46
- 241000628997 Flos Species 0.000 claims description 34
- 241000208340 Araliaceae Species 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 18
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 16
- 230000007062 hydrolysis Effects 0.000 claims description 15
- 238000006460 hydrolysis reaction Methods 0.000 claims description 15
- 235000020733 paullinia cupana extract Nutrition 0.000 claims description 15
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 13
- 241000412404 Fagus longipetiolata Species 0.000 claims description 13
- 229940041514 candida albicans extract Drugs 0.000 claims description 13
- 239000012138 yeast extract Substances 0.000 claims description 13
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims 2
- 229920002498 Beta-glucan Polymers 0.000 claims 2
- 229920001661 Chitosan Polymers 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 238000007599 discharging Methods 0.000 claims 1
- 230000004089 microcirculation Effects 0.000 abstract description 9
- 230000004054 inflammatory process Effects 0.000 abstract description 7
- 239000008187 granular material Substances 0.000 abstract description 4
- 230000003020 moisturizing effect Effects 0.000 abstract description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 abstract 3
- 235000007866 Chamaemelum nobile Nutrition 0.000 abstract 1
- 240000005250 Chrysanthemum indicum Species 0.000 abstract 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 abstract 1
- 241001070947 Fagus Species 0.000 abstract 1
- 244000042664 Matricaria chamomilla Species 0.000 abstract 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 abstract 1
- 240000003444 Paullinia cupana Species 0.000 abstract 1
- 235000000556 Paullinia cupana Nutrition 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- WQZGKKKJIJFFOK-UHFFFAOYSA-N hexopyranose Chemical compound OCC1OC(O)C(O)C(O)C1O WQZGKKKJIJFFOK-UHFFFAOYSA-N 0.000 abstract 1
- 235000019707 mung bean protein Nutrition 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 53
- 230000000694 effects Effects 0.000 description 15
- 210000003491 skin Anatomy 0.000 description 12
- 210000000744 eyelid Anatomy 0.000 description 8
- 239000002994 raw material Substances 0.000 description 5
- 208000003464 asthenopia Diseases 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 241000459479 Capsula Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000150100 Margo Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N 3‐isothujone Chemical compound CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 229930185660 Chrysanthone Natural products 0.000 description 1
- RKWHWFONKJEUEF-GQUPQBGVSA-O Cyanidin 3-O-glucoside Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 RKWHWFONKJEUEF-GQUPQBGVSA-O 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 229930135083 Pyrenoline A+ Natural products 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- -1 antiseptic Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
The invention discloses an eye-pouch-removing and anti-inflammation eye essence liquid which can significantly improve eye pouch and improve micro-circulation and inflammation, is free of generation of fat granule and is outstanding in water-supplying and moisturizing performance. On the basis of the total mass of the eye essence liquid, the eye essence liquid includes following components, by mass: 1-1.5% of carboxymethyl glucan, 1.5-3% of glycerinum, 0.05-1% of hyaluronic acid, 1-1.5% of hydrolyzed mung bean protein liquid, 1-1.5% of extract liquid of west Indian cherry, 2-3% of chamomile hydrosol, 1-2% of extract liquid of chrysanthemum indicum, 2-2.5% of extract liquid of ginseng, 2-3% of extract of guarana, 0.5-0.8% of extract liquid of yeast, 1-1.5% of extract liquid of beech trees, 0.2-0.3% of 1,2-hexylene glycol and 0.1% of ethyoxyl diethylene glycol.
Description
Technical field
The present invention relates to a kind of eye essence, specifically, be a kind of eye essence improving eye pouch and inflammatory reaction, belong to daily chemical products technical field.
Background technology
Universal along with computer and smart mobile phone, people too much cause eye microcirculation disturbance with eye, eye pouch and black eye problem more and more serious, and along with the raising of people's living standard, the pursuit of people to U.S. is more and more higher, people are in the urgent need to really effectively improving eye problems, and the eyeware products and solution for lenses and contact lenses of reasonable price.
At cosmetic eye-care product scope, the product improving eye problems often or price is very expensive, or effect is bad, or zest is higher, even causes the generation of fat granule.
The present invention aims to provide one kind of multiple component Synergistics, raw material natural green, and cost is reasonable, removes eye pouch antiinflammatory, also can alleviate the eye essence of eye strain.
Summary of the invention
Based on the technical problem that background technology exists, the present invention is directed to current eye product Problems existing, provide a kind of improvement microcirculation newly, especially remove the eye essence of eye pouch antiinflammatory.
It is too fat to move that eye pouch refers to that lower eyelid portion organizes, and hangs from above in bag-shaped.In frame, fat content and the supportive structure of lower eyelid maintain poised state under normal circumstances, when due to capsula adiposa bulbi overheap or lower eyelid, this balance is supported that structure thin is weak and is changed, the restriction that capsula adiposa bulbi breaks through lower eyelid protrudes from outside socket of the eye, namely forms the bag-shaped deformity of lower eyelid.Clinical manifestation is that skin of lower eyelid is lax, accumulation, capsula adiposa bulbi is deviate to hang from above in bag-shaped, outer canthus position moves down, lower margo palpebrae and eyeball are fitted not tight, lower margo palpebrae radian increases, move excessive tear outside lower lacrimal point, the aging absorption of facial skeleton causes lower eyelid supporting structure secondary to relax, and is the main cause that person in middle and old age's eye pouch is formed.
On the whole, the abnormal protuberantia of eyelid is that the accumulation in the accumulation socket of the eye eye region of the liquid that inflammatory reaction causes and fat causes because microcirculation is not smooth.Specifically can be divided into two kinds of hypotypes, lard type and edema type.
Therefore, wanting really to improve eye pouch, needing from improving microcirculation, promote discharge opeing, degraded fat, tightens up the many-sides such as skin and starts with, also will take into account the mildness of eye essence, moisture retention, and consider cost.
The present inventor is carrying out a large amount of experiments, attempts large content of starting materials, in the process of proportioning, has chanced on a kind of formula, and its eye essence moisturizing of making is good, and good absorbing, can not cause fat granule, and has the improvement eye pouch of highly significant, the effect of antiinflammatory.In addition, also find that it has the effect alleviating eye strain.
Sensor Chip CM 5 is that the first has the cosmetics bio feedstocks starting the effect of skin self epidemic preventing mechanism; it is by active cell immune system thus reach and improve the immunocompetence of skin; the synthesis of protection collagen protein; improve the elasticity of skin; repair damaged skin; diminish inflammation and antiallergic, also there is photoprotection simultaneously.
Hydrolysis Semen phaseoli radiati albumen polypeptide, be that raw material adopts advanced biological enzyme hydrolysis technique with Semen phaseoli radiati albumen, through enzymolysis, refining low molecular polypeptide, utilize HPLC Accurate Measurement sample protein molecular weight distribution, its molecular weight is mainly distributed between 408.41 ~ 1830.64.Semen phaseoli radiati peptide is rich in each seed amino acid, especially lysine content more very, research worker carries out the preliminary study of whitening and anti-oxidation efficacy to Semen phaseoli radiati polypeptide liquid, result shows, when sample concentration is 10%, tyrosinase inhibition rate is 49.98%, DPPH free radical scavenging activity be 69.14%, OH (hydroxyl Bai Youji) clearance rate is 58.62%.
Flos Chrysanthemi Indici extracting solution is the head titbit of feverfew Herba Dendranthematis indici.Containing acacetin-7-rhamnose Fructus Vitis viniferae glycoside, Flos Chrysanthemi Indici lactone, Chrysanthemin, bitter principle, chrysol, chrysanthone, northern Camphora, another containing retinoid material and vitamin B1, there is balanced fat secretion, suppress anti-pox, prevent that powder is perverse, the effect of bactericidal antiphlogistic.
Guarana extract, extracts from brazilian cocoa seed, containing the caffeine determining content.The activity being hydrolyzed into fatty acid and glycerol by measuring triglyceride confirms its steatolysis characteristic.
Radix Ginseng is the root of Araliaceae Radix Ginseng, platymiscium Radix Ginseng, and containing ginsengenin 20 .4% in its composition root, ginsenoside A, B, C, D, E and F etc., also have multivitamin, several amino acids etc.Its various nutrients, can increase the vigor of cell, delay senility, also can the generation of check melanin.Its extracting solution is nourishing additive agent fabulous in cosmetics.
Flos Matricariae chamomillae is called as in Latin language " noble flower ", be called as " Fructus Mali pumilae fairy maiden " in ancient Greek, Egyptian dedicates Flos Matricariae chamomillae to the sun, and praises highly as SHENCAO, offer a sacrifice to gods or ancestors the problem used as process neuralgia, stinging with Flos Matricariae chamomillae treatment Serpentis in Rome period is the basic general knowledge of the common people.Flos Matricariae chamomillae is rich in flavonoid active component, and this composition has antioxidation, antiangiogenic, antiinflammatory, anti-allergy and antiviral effect.Flos Matricariae chamomillae primary efficacy: improve comedo, allergy, eczema, burn and scald, can say it is to one of best hydrosol of skin.Treatment pimples, herpes, eczema, tinea, microvascular have good effect; Can be used for protecting the most responsive eye skin of face, for treatment acne vulgaris and red seal Be very effective, increase skin resistance.
Technical scheme of the present invention is as follows:
Improve an eye essence for eye pouch, relative to the gross mass of essence, containing following component:
Sensor Chip CM 5 1%-1.5%, glycerol 1.5-3%, hyaluronic acid 0.05%-0.1%, hydrolysis Semen phaseoli radiati albumen liquid 1%-1.5%; West Indian cherry extracting solution 1-1.5%; Flos Matricariae chamomillae hydrosol 2%-3%; Flos Chrysanthemi Indici extracting solution 1%-2%; Radix Ginseng extractive solution 2%-2.5%; Guarana extract 2%-3%; Yeast extract 0.5%-0.8%, Fagus sinensis Oliv. tree extract 1-1.5%, 1,2-hexanediol 0.2%-0.3%, ethoxydiglycol 0.1%.
Preferably, in described essence, relative to the gross mass of essence, also containing following component:
Water-soluble azone 0.5%-2.0%.
Preferably, in described essence, relative to the gross mass of essence, composed of the following components:
Sensor Chip CM 5 1%, glycerol 3%, hyaluronic acid 0.05%, hydrolysis Semen phaseoli radiati albumen liquid 1.5%; West Indian cherry extracting solution 1%; Flos Matricariae chamomillae hydrosol 3%; Flos Chrysanthemi Indici extracting solution 1%; Radix Ginseng extractive solution 2.5%; Guarana extract 3%; Yeast extract 0.8%, Fagus sinensis Oliv. tree extract 1.5%, 1,2-hexanediol 0.3%, ethoxydiglycol 0.1%.
Go a preparation method for the eye essence of eye pouch antiinflammatory, comprise the following steps:
(1) prepare according to percentage by weight: glycerol 1.5-3%, the aqueous solution of hyaluronic acid 0.05%-0.1%, is heated to 80-85 DEG C, stirs, makes it dissolve completely;
(2) be cooled to less than 40 DEG C, add according to essence gross mass: Sensor Chip CM 5 1%-1.5%, hydrolysis Semen phaseoli radiati albumen liquid 1%-1.5%; West Indian cherry extracting solution 1-1.5%; Flos Matricariae chamomillae hydrosol 2%-3%; Flos Chrysanthemi Indici extracting solution 1%-2%; Radix Ginseng extractive solution 2%-2.5%; Guarana extract 2%-3%; Yeast extract 0.5%-0.8%, Fagus sinensis Oliv. tree extract 1-1.5%, 1,2-hexanediol 0.2%-0.3%, ethoxydiglycol 0.1%.
Preferably, described goes in the preparation method of the eye essence of eye pouch antiinflammatory, and described each raw material weight percentage ratio is: Sensor Chip CM 5 1%, glycerol 3%, hyaluronic acid 0.05%, hydrolysis Semen phaseoli radiati albumen liquid 1.5%; West Indian cherry extracting solution 1%; Flos Matricariae chamomillae hydrosol 3%; Flos Chrysanthemi Indici extracting solution 1%; Radix Ginseng extractive solution 2.5%; Guarana extract 3%; Yeast extract 0.8%, Fagus sinensis Oliv. tree extract 1.5%, 1,2-hexanediol 0.3%, ethoxydiglycol 0.1%.
Usefulness of the present invention is:
1, essence skinfeel of the present invention is good, and replenishing water and preserving moisture is effective, and has outstanding improvement all kinds eye pouch, improves eye microcirculation, the effect of eye strain of releiving.
2, essence processing technology of the present invention is simple, with low cost.
3, essence of the present invention is not containing ethanol, antiseptic, and raw material natural green is without any side effects.
Accompanying drawing explanation
Fig. 1 is cascade of response of inflammation schematic diagram.
Detailed description of the invention
The all raw materials of the present invention can be obtained by conventional method, as " enzymatic hydrolysis of Semen phaseoli radiati albumen ", " food research and development " the 3rd phase in 2007, also can be buied by commercially available.Flos Chrysanthemi Indici extracting solution, Radix Ginseng extractive solution etc. also can extract with conventional water extraction, also have the product that a large amount of company's supplies is relevant on the market.
Guarana extract, west Indian cherry extracting solution, yeast extract, Fagus sinensis Oliv. tree extract praises Master company purchased from France.
The extracting solution that all embodiments of other the present invention are used is purchased from Sheng Tong bio tech ltd, Guangzhou.
Embodiment 1:
Go a preparation method for the eye essence of eye pouch antiinflammatory, comprise the following steps:
Prepare according to percentage by weight: glycerol 3%, the aqueous solution of hyaluronic acid 0.05%, be heated to 85 DEG C, stir, make it dissolve completely;
Be cooled to less than 40 DEG C, add according to essence gross mass: Sensor Chip CM 5 1%, hydrolysis Semen phaseoli radiati albumen liquid 1.5%; West Indian cherry (lyophilized powder) extracting solution 1%; Flos Matricariae chamomillae hydrosol 3%; Flos Chrysanthemi Indici extracting solution 1%; Radix Ginseng extractive solution 2.5%; Guarana extract 3%; Yeast extract 0.8%, Fagus sinensis Oliv. tree extract 1.5%, 1,2-hexanediol 0.3%, ethoxydiglycol 0.1%.
Embodiment 2:
Go a preparation method for the eye essence of eye pouch antiinflammatory, comprise the following steps:
Prepare according to percentage by weight: glycerol 2%, the aqueous solution of hyaluronic acid 0.1%, be heated to 83 DEG C, stir, make it dissolve completely;
Be cooled to less than 40 DEG C, add according to essence gross mass: Sensor Chip CM 5 1.5%, hydrolysis Semen phaseoli radiati albumen liquid 1.1%; West Indian cherry extracting solution 1.5%; Flos Matricariae chamomillae hydrosol 2%; Flos Chrysanthemi Indici extracting solution 2%; Radix Ginseng extractive solution 2.1%; Guarana extract 2%; Yeast extract 0.5%, Fagus sinensis Oliv. tree extract 1%, 1,2-hexanediol 0.2%, ethoxydiglycol 0.1%.
Embodiment 3:
Go a preparation method for the eye essence of eye pouch antiinflammatory, comprise the following steps:
Prepare according to percentage by weight: glycerol 1.5%, the aqueous solution of hyaluronic acid 0.09%, be heated to 82 DEG C, stir, make it dissolve completely;
Be cooled to less than 40 DEG C, add according to essence gross mass: Sensor Chip CM 5 1.3%, hydrolysis Semen phaseoli radiati albumen liquid 1%; West Indian cherry extracting solution 1.3%; Flos Matricariae chamomillae hydrosol 2%; Flos Chrysanthemi Indici extracting solution 1%; Radix Ginseng extractive solution 2%; Guarana extract 3%; Yeast extract 0.7%, Fagus sinensis Oliv. tree extract 1.4%, 1,2-hexanediol 0.3%, ethoxydiglycol 0.1%.
Embodiment 4:
Go a preparation method for the eye essence of eye pouch antiinflammatory, comprise the following steps:
Prepare according to percentage by weight: glycerol 2.5%, the aqueous solution of hyaluronic acid 0.07%, be heated to 84 DEG C, stir, make it dissolve completely;
Be cooled to less than 40 DEG C, add according to essence gross mass: Sensor Chip CM 5 1.2%, hydrolysis Semen phaseoli radiati albumen liquid 1.4%; West Indian cherry extracting solution 1.1%; Flos Matricariae chamomillae hydrosol 3%; Flos Chrysanthemi Indici extracting solution 2%; Radix Ginseng extractive solution 2.2%; Guarana extract 2%; Yeast extract 0.6%, Fagus sinensis Oliv. tree extract 1.2%, 1,2-hexanediol 0.2%, ethoxydiglycol 0.1%.
Embodiment 5:
Go a preparation method for the eye essence of eye pouch antiinflammatory, comprise the following steps:
Prepare according to percentage by weight: glycerol 1.8%, the aqueous solution of hyaluronic acid 0.08%, be heated to 80 DEG C, stir, make it dissolve completely;
Be cooled to less than 40 DEG C, add according to essence gross mass: Sensor Chip CM 5 1.4%, hydrolysis Semen phaseoli radiati albumen liquid 1.2%; West Indian cherry extracting solution 1.4%; Flos Matricariae chamomillae hydrosol 2%; Flos Chrysanthemi Indici extracting solution 1%; Radix Ginseng extractive solution 2.4%; Guarana extract 3%; Yeast extract 0.8%, Fagus sinensis Oliv. tree extract 1.3%, 1,2-hexanediol 0.3%, ethoxydiglycol 0.1%.
Embodiment 6:
(1) Cell culture invitro test
Carry out In vitro culture to Human Keratinocytes, carry out process 48 hours with eye essence of the present invention, test various enzyme and live and extracellular matrix material, result is as shown in table 1:
Table 1
Cascade of response of inflammation figure shown in Figure 1, from the data of table 1, eye essence of the present invention effectively can reduce inflammatory reaction, promotes collagen protein regeneration, thus reaches the effect of the eye part skin that compacts.
(2) improvement of microcirculation and discharge opeing effect is activated
50 volunteers, between 25-40 year, all there is eye pouch in various degree at the age, is divided into 5 groups, often organize 10 people, often no significant difference between group.Carry out test in 28 days, use 2 eye essence of the present invention every day.Evaluate parameter: blood flow, instrument: DOPPLER-POWER Doppler energy is ultrasonic.
Result is as shown in table 2:
Table 2
As can be seen here, eye essence of the present invention also has well activation microcirculation and discharge opeing effect, significantly can improve microcirculation.Dermatology doctor assesses going eye pouch effect, and each group effective percentage all reaches more than 90.
(3) other use senses are subject to
50 volunteers do not have an example irritated, all reacts and use as snug as a bug in a rug, good absorption, and 45 reactions obviously can feel the effect having eye strain of releiving.In addition, an example is not had to occur extra eye fat granule after 28 days.
The tracking and measuring moistening effect of 8 hours: in 30 minutes, the hydration of eye part skin increases 71-75%; After 8 hours, the hydration of eye part skin still keeps increasing 46-48%.
Visible, the replenishing water and preserving moisture performance of eye essence of the present invention is also very outstanding.
The above; be only the present invention's preferably detailed description of the invention; but protection scope of the present invention is not limited thereto; anyly be familiar with those skilled in the art in the technical scope that the present invention discloses; be equal to according to technical scheme of the present invention and inventive concept thereof and replace or change, all should be encompassed within protection scope of the present invention.
Claims (4)
1. remove an eye essence for eye pouch antiinflammatory, it is characterized in that: relative to the gross mass of essence, containing following component:
Beta glucan 1%-1.5%, glycerol 1.5-3%, hyaluronic acid 0.05%-0.1%, hydrolysis Semen phaseoli radiati albumen liquid 1%-1.5%; West Indian cherry extracting solution 1-1.5%; Flos Matricariae chamomillae hydrosol 2%-3%; Flos Chrysanthemi Indici extracting solution 1%-2%; Radix Ginseng extractive solution 2%-2.5%; Guarana extract 2%-3%; Yeast extract 0.5%-0.8%, Fagus sinensis Oliv. tree extract 1%-1.5%, 1,2-hexanediol 0.2%-0.3%, ethoxydiglycol 0.1%.
2. the eye essence removing eye pouch antiinflammatory according to claim 1, is characterized in that: relative to the gross mass of essence, containing following component:
Sensor Chip CM 5 1%, glycerol 3%, hyaluronic acid 0.05%, hydrolysis Semen phaseoli radiati albumen liquid 1.5%; West Indian cherry extracting solution 1%; Flos Matricariae chamomillae hydrosol 3%; Flos Chrysanthemi Indici extracting solution 1%; Radix Ginseng extractive solution 2.5%; Guarana extract 3%; Yeast extract 0.8%, Fagus sinensis Oliv. tree extract 1.5%, 1,2-hexanediol 0.3%, ethoxydiglycol 0.1%.
3. go a preparation method for the eye essence of eye pouch antiinflammatory, comprise the following steps:
(1) prepare according to percentage by weight: beta glucan 2%-3.5%, hyaluronic acid 0.05%-0.1%, the aqueous solution of water-soluble chitosan 0.5%-0.8%, is heated to 80-85 DEG C, stirs, makes it dissolve completely;
(2) be cooled to less than 40 DEG C, add according to essence gross mass: hydrolysed egg proteins polypeptide liquid 3%-4.5%; Hydrolysis Semen phaseoli radiati albumen liquid 1%-2%; Flos Matricariae chamomillae hydrosol 3%-5%; Flos Chrysanthemi Indici extracting solution 1%-2%; Radix Ginseng extractive solution 1%-2%; Radix Angelicae Sinensis extracting solution 1%-2%; Guarana extract 1%-1.5%; 1,2-hexanediol 0.2%-0.3%, water-soluble azone 1%, mix homogeneously, discharging.
4. preparation method of removing the essence of eye pouch antiinflammatory according to claim 3, is characterized in that: Sensor Chip CM 5 1%, glycerol 3%, hyaluronic acid 0.05%, hydrolysis Semen phaseoli radiati albumen liquid 1.5%; West Indian cherry extracting solution 1%; Flos Matricariae chamomillae hydrosol 3%; Flos Chrysanthemi Indici extracting solution 1%; Radix Ginseng extractive solution 2.5%; Guarana extract 3%; Yeast extract 0.8%, Fagus sinensis Oliv. tree extract 1.5%, 1,2-hexanediol 0.3%, ethoxydiglycol 0.1%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510119659.3A CN104758235B (en) | 2015-03-18 | 2015-03-18 | A kind of eye essence for removing pouch anti-inflammatory |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510119659.3A CN104758235B (en) | 2015-03-18 | 2015-03-18 | A kind of eye essence for removing pouch anti-inflammatory |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104758235A true CN104758235A (en) | 2015-07-08 |
| CN104758235B CN104758235B (en) | 2018-05-01 |
Family
ID=53640574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510119659.3A Active CN104758235B (en) | 2015-03-18 | 2015-03-18 | A kind of eye essence for removing pouch anti-inflammatory |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104758235B (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105267130A (en) * | 2015-11-30 | 2016-01-27 | 戴女裕 | Chamomile eyeshadow cream and preparation method thereof |
| CN105287349A (en) * | 2015-11-30 | 2016-02-03 | 戴女裕 | Ormosia eye shadow paste and preparation method thereof |
| CN105287350A (en) * | 2015-11-30 | 2016-02-03 | 戴女裕 | Almond eyeshadow cream and preparation method thereof |
| CN105287348A (en) * | 2015-11-30 | 2016-02-03 | 戴女裕 | Yam eye shadow cream and preparation method thereof |
| CN105326761A (en) * | 2015-11-30 | 2016-02-17 | 戴女裕 | Fructus forsythia eye shadow cream and preparation method thereof |
| CN105326757A (en) * | 2015-11-30 | 2016-02-17 | 戴女裕 | Ginseng eye shadow cream and preparation method thereof |
| CN105342961A (en) * | 2015-11-30 | 2016-02-24 | 戴女裕 | Semen euryales eyeshadow cream and preparing method thereof |
| CN105395449A (en) * | 2015-11-30 | 2016-03-16 | 戴女裕 | Eye-shadow cream containing coix seed and preparation method of eye-shadow cream |
| CN107233283A (en) * | 2017-07-06 | 2017-10-10 | 贵州九立德生物制药有限公司 | A kind of elimination pouch, hydrogel of wrinkle and preparation method thereof |
| CN108403506A (en) * | 2018-04-25 | 2018-08-17 | 姜凤艳 | Crease-resistant reparation eye cream of one kind and preparation method thereof |
| CN110917093A (en) * | 2019-12-17 | 2020-03-27 | 天津市尖峰天然产物研究开发有限公司 | Composite eye essence and steam eye mask composition |
| CN112043734A (en) * | 2019-05-20 | 2020-12-08 | 百岳特生物技术（上海）有限公司 | Use of acerola cherry young fruit extract for regulating body weight, beautifying skin, resisting inflammation and resisting aging |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102657590A (en) * | 2012-05-18 | 2012-09-12 | 通德集团有限公司 | Rhodiola crenulata essence with effects of whitening, moisturizing and wrinkle resisting |
| CN102657592A (en) * | 2012-06-06 | 2012-09-12 | 广州舒泰生物技术有限公司 | Anti-aging essence composition and preparation method thereof |
-
2015
- 2015-03-18 CN CN201510119659.3A patent/CN104758235B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102657590A (en) * | 2012-05-18 | 2012-09-12 | 通德集团有限公司 | Rhodiola crenulata essence with effects of whitening, moisturizing and wrinkle resisting |
| CN102657592A (en) * | 2012-06-06 | 2012-09-12 | 广州舒泰生物技术有限公司 | Anti-aging essence composition and preparation method thereof |
Non-Patent Citations (4)
| Title |
|---|
| 左小霞，等: "《蜂胶保健与防病治病妙用》", 31 March 2011 * |
| 张拓伟: "《很老很老的老偏方.女性常见病奇效方一本全》", 31 May 2014 * |
| 王建新: "《化妆品植物原料大全》", 30 June 2012 * |
| 王建新: "《化妆品植物原料手册》", 30 June 2009 * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105267130A (en) * | 2015-11-30 | 2016-01-27 | 戴女裕 | Chamomile eyeshadow cream and preparation method thereof |
| CN105287349A (en) * | 2015-11-30 | 2016-02-03 | 戴女裕 | Ormosia eye shadow paste and preparation method thereof |
| CN105287350A (en) * | 2015-11-30 | 2016-02-03 | 戴女裕 | Almond eyeshadow cream and preparation method thereof |
| CN105287348A (en) * | 2015-11-30 | 2016-02-03 | 戴女裕 | Yam eye shadow cream and preparation method thereof |
| CN105326761A (en) * | 2015-11-30 | 2016-02-17 | 戴女裕 | Fructus forsythia eye shadow cream and preparation method thereof |
| CN105326757A (en) * | 2015-11-30 | 2016-02-17 | 戴女裕 | Ginseng eye shadow cream and preparation method thereof |
| CN105342961A (en) * | 2015-11-30 | 2016-02-24 | 戴女裕 | Semen euryales eyeshadow cream and preparing method thereof |
| CN105395449A (en) * | 2015-11-30 | 2016-03-16 | 戴女裕 | Eye-shadow cream containing coix seed and preparation method of eye-shadow cream |
| CN107233283A (en) * | 2017-07-06 | 2017-10-10 | 贵州九立德生物制药有限公司 | A kind of elimination pouch, hydrogel of wrinkle and preparation method thereof |
| CN108403506A (en) * | 2018-04-25 | 2018-08-17 | 姜凤艳 | Crease-resistant reparation eye cream of one kind and preparation method thereof |
| CN112043734A (en) * | 2019-05-20 | 2020-12-08 | 百岳特生物技术（上海）有限公司 | Use of acerola cherry young fruit extract for regulating body weight, beautifying skin, resisting inflammation and resisting aging |
| CN110917093A (en) * | 2019-12-17 | 2020-03-27 | 天津市尖峰天然产物研究开发有限公司 | Composite eye essence and steam eye mask composition |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104758235B (en) | 2018-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104758235A (en) | Eye-pouch-removing and anti-inflammation eye essence liquid | |
| CN110200830B (en) | Anti-inflammatory and allergy-relieving repair composition and preparation method and application thereof | |
| CN103284940B (en) | Saccharomycetes fermented traditional Chinese medicine composition, as well as preparation method and application thereof | |
| CN105687055B (en) | A kind of eye maintenance Essence and preparation method thereof | |
| CN101873847B (en) | Composition for skin external application containing complex of herbal extracts | |
| CN103405379B (en) | A kind ofly be rich in amino acid whose cosmetic composition and the application in skin care item thereof | |
| CN110731974B (en) | Skin external composition with enhanced anti-inflammatory efficacy | |
| CN113694115A (en) | Application of Fuzhuan tea extract in preparation of skin conditioning product | |
| CN107913218A (en) | A kind of compound elite preparation with senile-resistant efficacy and its preparation method and application | |
| CN105147584B (en) | A kind of yeast product and its preparation method and application containing traditional Chinese medicine ingredients | |
| CN110974763A (en) | All-natural plant anti-allergy repair essence and preparation method thereof | |
| CN108670901B (en) | A kind of skin softening lotion using macadamia nut protein peptide and green skin extract as active ingredients and preparation method thereof | |
| CN102274141B (en) | Herba selaginellae revival moisturizing cream and preparation method thereof | |
| CN110496072A (en) | A kind of vibration massage function eye cream of the filtrate containing glossy ganoderma fermentation and preparation method thereof | |
| CN106309340A (en) | Grapefruit juice anti-wrinkle skin care formula | |
| CN109223677B (en) | Coix seed hydrolysate, preparation method thereof and application of coix seed hydrolysate in cosmetics | |
| CN110974775A (en) | Allergy-relieving composition containing nostoc sphaeroides and preparation method and application thereof | |
| CN108703909B (en) | Composition with anti-wrinkle and anti-aging effects and application of composition in cosmetics | |
| CN104758207B (en) | One kind improves black-eyed eye essence | |
| CN108969438B (en) | Anti-wrinkle cream containing bletilla striata extract, chaenomeles speciosa extract and hairyvein agrimony extract and preparation method thereof | |
| CN113143820A (en) | Anti-aging composition and preparation method thereof | |
| CN118267339A (en) | Preparation and application of nourishing and anti-wrinkle face cream | |
| CN103340808B (en) | A kind of preparation technology of pseudo-ginseng medicament night cream | |
| KR102583304B1 (en) | Composition for Anti-glycation, Whitening and Skin Condition Improvement Comprising Plant Complex Extracts as Active Ingredient | |
| KR102221137B1 (en) | A lycoris uydoensis extract comprising anti-wrinkle, anti-inflammatory, anti-oxidation activity, and composition comprising the same, and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Guogang Inventor before: Wu Genhua |
|
| CB03 | Change of inventor or designer information | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20180408 Address after: 510470 Guangzhou Baiyun District, Guangzhou, Guangdong Province, and No. 9 Xingda Road, Xicheng Industrial Zone Applicant after: Guangzhou Saint Fang Pharmaceutical Technology Co., Ltd. Address before: 313000 2 C509, 1236 Dragon King Road, Huzhou economic and Technological Development Zone, Zhejiang, China Applicant before: Huzhou Pin Chuan brooder company limited |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |